Abeona Therapeutics Inc.

Abeona Therapeutics Inc. is not a good value stock. Abeona Therapeutics Inc. is not very popular among insiders. Abeona Therapeutics Inc. is a mediocre stock to choose.
Log in to see more information.
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the develo...

News

Abeona Therapeutics  Announces Participation in Upcoming Investor Conferences
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences

Globe Newswire CLEVELAND, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in...\n more…

Abeona Therapeutics  Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity...\n more…

Research Analysts Offer Predictions for Abeona Therapeutics Inc's FY2024 Earnings (NASDAQ:ABEO)
Research Analysts Offer Predictions for Abeona Therapeutics Inc's FY2024 Earnings (NASDAQ:ABEO)

Ticker Report Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Stock analysts at Zacks Small Cap raised their FY2024 earnings estimates for Abeona Therapeutics in a report released on Wednesday, August 14th...\n more…

Q3 2024 Earnings Estimate for Abeona Therapeutics Inc Issued By HC Wainwright (NASDAQ:ABEO)
Q3 2024 Earnings Estimate for Abeona Therapeutics Inc Issued By HC Wainwright (NASDAQ:ABEO)

Ticker Report Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright cut their Q3 2024 earnings per share estimates for shares of Abeona Therapeutics in a research note issued...\n more…

Abeona Therapeutics Inc.'s (NASDAQ:ABEO) large institutional owners must be happy as stock continues to impress, up 12% over the past week
Abeona Therapeutics Inc.'s (NASDAQ:ABEO) large institutional owners must be happy as stock continues to impress, up 12% over the past week

Simply Wall St Key Insights Significantly high institutional ownership implies Abeona Therapeutics' stock price is sensitive to their...\n more…

Abeona Therapeutics Enhances Board with Industry Experts
Abeona Therapeutics Enhances Board with Industry Experts

TipRanks Financial Blog The latest announcement is out from Abeona Therapeutics (ABEO). Abeona Therapeutics Inc. has strengthened its Board of Directors with the appointment of Dr. Bernhar...\n more…